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ABSTRACT
Current TNM staging system derived empirically from human papillomavirus (HPV) unrelated
oropharyngeal cancer (OPC) has been shown inadequate to predict survival for HPV-related
OPC. This study used three recursive partitioning algorithms, Classification Trees (CART),
Conditional Inference Trees (CTree) and Model-based Recursive Partitioning (MOB) to derive a
new staging scheme based on data from the National Cancer Data Base (NCDB). The derived
staging systems were compared to the current system using the criteria such as hazard
consistency within staging groups, hazard discrimination between groups, predictive ability and
balance of distribution across groups. A total of 5,712 patients were included in the analysis. The
staging system derived using the model-based recursive partitioning (MOB) has the best
predictive ability and overall performance. It separates patients into four stages: Stage I (T12N0-2a), Stage II (T1-2N2b-3), Stage III (T3), and Stage IV (T4). Stage V is reserved for
metastatic patients (M1). The theoretical advantages for the MOB algorithm of fitting the local
parametric model in each node and adjusting for covariates affecting survival were confirmed
with empirical analysis. Thus MOB algorithm is recommended for future TNM cancer staging
studies.
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INTRODUCTION
Oropharyngeal carcinoma (OPC) is a type of head and neck cancer with a rising incidence in the
United States (Chaturvedi et al, 2011). An increasing proportion of OPC is related with human
papillomavirus (HPV) infection (Ernster, 2007). OPC staging system that defines homogeneous
populations is essential for selecting treatment, assessing prognosis and interpreting outcomes
(Sobin, Gospodarowicz and Wittekind, 2010).
Currently, the American Joint Committee on Cancer (AJCC)/ Union for International Cancer
Control (UICC) TNM staging system is widely accepted for OPC patients (Greene and Sobin,
2002). The extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence
of metastasis (M) categories combine to create staging groups from I to IV that stratify patients
according to survival outcomes. The seventh edition AJCC system was derived empirically from
smoking-related (i.e. human papillomavirus (HPV) unrelated) OPC outcomes (Edge, Byrd and
Compton, 2010). Researchers have shown that this staging system is not adequate to predict
survival for HPV-related OPC (Ward et al., 2015; Huang et al., 2015; Dahlstrom et al., 2013),
thus a separate staging system is needed.
Recently, Huang et al. (2015) proposed a new staging system for HPV-related OPC using
recursive partitioning analysis (RPA). Dahlstrom et al. (2016) and O’sulllivan et al. (2016)
externally validate Huang’s RPA staging system based on HPC-related OPC patients treated at
their institution and developed new staging systems with RPA as well.
Recursive partitioning is a tree-based regression modeling technique introduced by Morgan and
Sonquist (1963). The implementations of such algorithm includes Classification and Regression
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Trees (CART), Multivariate Adaptive Regression Splines (MARS), and their variants and
extensions (Zhang and Singer, 2010). The algorithm consists of two stages: first partition the
observations by the covariate showing the best split that maximized an information measure of
node impurity in a recursive way, and second fit a regression model in each node of the resulting
partition. Gordon and Olshen (1985) first adapted the method of recursive partitioning to
censored outcomes. The idea behind their algorithm was to force each node to be homogeneous
as measured by a distance metric between the within-node Kaplan-Meier survival function and a
survival function that has mass on at most one finite point (Bou-Hamad et al., 2011). Other
splitting criteria using the logrank statistic (Ciampi et al., 1986; Segal, 1988) or likelihood ratio
statistic (Davis and Anderson, 1989; LeBlanc and Crowley, 1992; Ciampi et al., 1995) was also
suggested.
Recursive partitioning has been widely used in TNM staging since the Radiation Therapy
Oncology Group (RTOG) applied RPA to their head and neck database and create homogeneous
groups based on anatomic and demographic factors (Cooper et al., 1996). Prognostic factors
(Shepherd et al., 1993; Roach et al., 2000; Chansky et al., 2009; Huang et al., 2015), anatomic
factors such as clinical T, N and M categories (Mountain, 1997; Rice et al., 2003; Huang et al.,
2015; Pan et al., 2016) and genetic characteristics (Zhang et al., 2001) are three common types of
partitioning covariates that the algorithm split nodes on. Using different splitting criteria and
pruning methods often results in different variable selection and splitting values, thus distinct
decision trees for staging would be created. But most researchers did not specify the splitting
criteria and pruning method being used for RPA, which makes the results unable to replicate and
makes it impossible to compare the effectiveness of different recursive partitioning models. In
this article various recursive partitioning algorithms, including Classification Trees (CART),
2

Conditional Inference Trees (CTree) and Model-based Recursive Partitioning (MOB) were
applied to HPV-related OPC patients, comparative evaluation for the derived staging systems
was performed. The goal of this study was to (1) compare the performance of different recursive
partitioning algorithms in cancer staging. (2) propose an alternative staging system for HPVrelated OPC that separate the patients into homogeneous groups with respect to survival.
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Theory of Recursive Partitioning Analysis for Censored Data
Recursive partitioning is a tree-based regression model introduced by Morgan and Sonquist
(1963). The algorithm consists of two stages: first partition the observations by the covariate
showing the best split in a recursive way, and second fit a regression model in each node of the
resulting partition. Gordon and Olshen (1985) first adapted the idea of recursive partitioning to
censored outcomes by forcing each node to be homogeneous. Theories for three recursive
partitioning algorithms available for censored data are introduced in the article.

Classification and Regression Trees
Classification and Regression Trees (CART) was introduced in 1984 by Breiman, Friedman,
Olshen and Stone as an umbrella term of classification trees and regression trees. They employed
a generalization of the binomial variance called the Gini index as the measure of node impurity
and split a node by exhaustively searching over all covariates that minimize the total impurity of
its two daughter nodes. The process is applied recursively until the relative decrease in total
impurity is below a pre-specified threshold.
The measure of node impurity for censored outcome was firstly developed by Gordon and
Olshen (1985). They regarded a node as pure if all failures in the node occurred at the same time
and defined P as the collection of all such Kaplan-Meier curves. The distance between withinnode Kaplan-Meier curve and any of the curves in P can be used to measure node impurity.
The pruning process for CART is conducted by choosing a best value for complexity parameter
using cross-validation. A cost-complexity of tree T is defined as

!" # = ! # + & #
4

[1]

where ! is the complexity parameter, ! is the number of terminal nodes in T, and ! " is the
sum of the costs over all terminal nodes. According to Breiman et al. (1984), for any value of the
complexity parameter ! , there is a unique smallest subtree of the initial tree !" that minimized
the cost-complexity. We first derive m typical values for complexity parameter spanning from 0
to infinity. Then fit a full model on the reduced training set with (n-n/s) observations and
determine the subtrees for each complexity parameter. Under each of the m models, predict the
outcome for each observation in the test set and sum over the cost of s subsets. The subtree
derived by the complexity parameter with the smallest cost is chosen as the best pruned tree.
(Therneau and Atkinson, 2015)

Conditional Inference Trees
Exhaustive search over all possible splits that maximize an information measure of node
impurity often leads to a selection bias towards covariates with many possible splits.
Hothorn, Hornik and Zeileis (2006) thus proposed Conditional Inference Trees (CTree), a nonparametric class of regression trees embedding tree-structured regression models into the theory
of permutation tests (Strasser and Weber, 1999), to fix this problem.
The CTree algorithm can be formulated using non-negative integer case weights
! = ($% , … , $( ). Each node is represented by a vector of case weights when the corresponding

observations are within this node. For case weights w test the global null hypothesis of
independence between any of the m covariates and the response variable. The association
between Y and !" was measured by a linear statistics of the form
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where !" is a non-random transformation of the covariate "# , h is the influence function
depending on the response ("# , … , "& ) in a permutation symmetric way. Under the null
hypothesis one can dispose the dependency of !" #$ , & on the joint distribution of Y and !" by
fixing the covariates and conditioning on all possible permutations of Y. Then standardize the
linear statistic and take the maximum of the absolute value and derive the P-value for the
conditional distribution of this new test statistic. Next split the node over the covariate

!" * with

strongest association to Y (i.e. minimum P-value). Recursively repeat this process until the null
hypothesis cannot be rejected at a pre-specified level ! .
For censored regression the influence function h may be chosen as Logrank or Savage scores
(Segal, 1988) and one can proceed as for univariate continuous regression. Alternatively, one can
use the weighting scheme suggested by Molinaro, Dudoit, and van der Laan (2004) and take the
weighted Kaplan-Meier curve for the case weights w(x) as prediction.

Model-Based Recursive Partitioning
Motivated by the fact that constant fits in each node tend to produce large and hard-to-interpret
trees (Chan and Loh, 2004), the incorporation of parametric models into recursive partitioning
has been of increased interest in the last decade (Zeileis et al., 2008). Inspired by algorithms of
GUIDE (Loh, 2002), CRUISE (Kim and Loh, 2001) and LOTUS (Chan and Loh, 2004) that
attached parametric models to terminal nodes, and maximum likelihood trees developed by Su
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wt al. (2004), Zeileis, Hothorn and Hornik (2008) introduced a framework that embeds recursive
partitioning into statistical model estimation and variable selection.
Consider a parametric model ! ($, &) observations ! and a !-dimensional vector of parameters

q. In many situations a single global model will not fit all n observations well. Then it might be
possible to partition the observations using another set of covariates !" , … , !% such that the model
can be well-fitted locally in each node.
The Model-based Recursive Partitioning (MOB) algorithm is used to find such a partition
adaptively using a greedy forward search. Firstly, fit the model to observations in the current
node by minimization of some objective function Ψ. If there is some overall instability in the
parameter estimates with respect to any of the partitioning variables !" , split the node over the
variable !" associated with the highest parameter instability. To assess whether the parameter
estimates are stable, the general class of score-based fluctuation test for parameter instability
(Zaileis and Hornik, 2007) is performed. The idea is to check whether the scores

! ", $ =

'((*,+)
'+

fluctuate randomly around their mean 0 or exhibit systematic deviations from

0 over !" . These deviations can be formulated as
23

W" # = %-'/) *-'/)

+,(./0)
45'

[3]

where !(#$% ) is the ordering permutation which gives the anti-rank of the observation !"# in the
vector !" , and ! is a suitable estimate of the covariate matric cov(% &, ( ). A test statistic can be
derived by applying a scalar function that captures the fluctuation in the empirical process to the
7

fluctuation process. Next compute the split point that locally optimize the Ψ. When no more
significant instabilities can be found, the recursion stops. Post-pruning can be applied by first
growing a large tree and then pruning back splits that did not improve the model based on
information criteria such as AIC or BIC (Su, Wang, and Fan, 2004).
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METHODS
Study population
This project was a retrospective study that included patients with HPV-related OPC from
National Cancer Data Base (NCDB). The NCDB is a joint project of the Commission on Cancer
(CoC) of the American College of Surgeons (ACS) and the American Cancer Society. It draws
from more than 1,500 hospital registries and captures approximately 70% of all newly diagnosed
cancer cases in the U.S. (Bilimoria et al. 2008) The database recorded patient demographics,
socioeconomic status, stage, tumor characteristics, comorbidity score, and treatment information.
Patients diagnosed with squamous cell carcinoma of the oropharynx between 2010-2012 were
enrolled in the study. Patients with unknown HPV status or HPV-negative status were excluded.
Patients with metastatic disease (M1) were also excluded from the analysis of RPA stage
derivation because they had distinct survival regardless of clinical T and N stages and only
comprised 1.5% of study population. The analysis was eventually conducted on 5,626 cases
meeting clinical and pathological inclusion criteria.

Statistical Analysis
Three variants of recursive partitioning algorithms for censored outcomes including CART,
CTree and MOB were used to determine the new staging system for HPV-related OPC. The
underlying statistical theories of the algorithms were elaborated in section 2. Table 1
summarizes the differences in splitting criteria, pruning method and program of implementation
of the three algorithms. Ordinal clinical T stage (T1/T2/T3/T4a/T4b) and clinical N stage
(N0/N1/N2a/N2b/N2c/N3) were entered into the model as possible partitioning variables. Age,
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Charlson-Deyo score and treatment were used to construct the parametric model in MOB
algorithm.
Table 1 Comparison of CART, CTree and MOB algorithms
Type of Model

Splitting Criteria

Pruning Method

Implementation
Program

CART

Nonparametric

Minimizing total node impurity
measured by the difference from
Kaplan-Meier curve to standard
curves

Choosing smallest
complexity parameter
using cross-validation

Rpart() function
from R package
Rpart

CTree

Nonparametric

Partitioning over the covariate
with strongest association to
response

None

Ctree() function
from R package
partykit

MOB

Parametric

Partitioning over the covariate
associated with the highest
parameter instability

Pruning back the splits
with no improvement
on AIC

Mob() function
from R package
partykit

3-year overall survival (OS) was calculated for the 7th edition AJCC staging groups, the proposed
CART-derived groups, the CTree-derived groups, and the MOB-derived groups using KaplanMeier method. Pairwise log-rank tests were used to detect differences in survival between
staging groups. Adjusted hazard ratio (AHR) with 95% confidence interval was derived using
cox proportional hazard models. Variables that had significant effect on survival in univariate
analysis, including age, Charlson-Deyo score and treatment were included in the final
multivariate model. All tests were two sided, and a P-value of < 0.05 was considered statistically
significant. Bonferroni correction was used for subgroup analysis and pairwise comparison.
The four staging systems were then evaluated using the criteria proposed by Groome et al.
(2001): (1) hazard consistency measuring whether observations within a staging group have
similar survival rate. A weighted average of the survival deviation between each staging group
and the TNM subgroups that comprise this staging group was used. (2) hazard discrimination
measuring whether the survival rates differ between staging groups. The average of a measure of
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evenness of the curves and the span of the curves was used. (3) outcome prediction is high. We
use Brier score (Gerds and Schumacher, 2006) and concordance probability estimate (CPE)
(Gönen and Heller, 2005) to measure the predictive and discriminative ability of the models. (4)
balance in the distribution of cases. As in the original Groome study, the first three criteria were
given a weight of 2 and balance was given a weight of 1. Different weights assignments were
also discussed. The overall score was then calculated. Bootstrap with replacement was performed
for internal validation.
R version 3.2.3 was used for all statistical analyses.
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RESULTS
Study Cohort Descriptive Analysis
A total of 5,712 patients with HPV-related OPC entered into the statistical analysis. The median
follow-up was 28.45 months (95% CI: 28.09 to 28.91), estimated using reverse Kaplan-Meier
method (Schemper and Smith, 1996). Demographic and clinical characteristics for the 5,626
patients are provided in Table 2. The median age was 58. Among those patients, 86% were men,
84% had no comorbid conditions recorded, 56% received primary radiation therapy and 41%
received primary surgical therapy. The distribution of clinical T and N categories is also listed in
the table.
Table 2 Demographic and Clinical Characteristics of 5,626 HPV-related OPC Patients
Characteristic
Age
Mean (Standard deviation)
Median (Quartiles)
Sex
Male
Female
Charlson-Deyo score

No. (%) of Patients Hazard Ratio (P-value)

0

58.43 (9.33)
58 (52, 64)

1.049 (< .001)

4,911 (85.98)
801 (14.02)

0.953 (0.67)

4,809 (84.19)

1
2+
Clinical T category
T1
T2
T3
T4a
T4b
Clinical N category
N0
N1
N2a
N2b
N2c
N3

12

726 (12.71)
177 (3.1)

1.967 (< .001)
1.023 (0.83)

1,732 (30.32)
2,480 (43.42)
895 (15.67)
491 (8.6)
114 (19.96)

4.082 (< .001)
0.906 (0.42)
0.955 (0.63)
1.022 (0.8)

814 (14.25)
1,113 (19.49)
640 (11.2)
2,099 (36.75)
822 (14.39)
224 (3.92)

1.963 (< .001)
2.204 (< .001)
0.735 (0.005)
0.854 (0.14)
1.212 (0.104)

Treatment
Primary radiation
Primary surgery
Other

3,222 (56.41)
2,361 (41.33)
129 (2.26)

0.698 (< .001)
0.365 (< .001)

Recursive Partitioning Analysis
Utilizing the recursive partitioning algorithms of CART, CTree and MOB, three TNM staging
systems were derived respectively. Figure 1 shows the tree-based staging groups
derived using CART with 3-year OS estimates, and Figure 1 B shows the combination
of clinical T and N categories for each staging group. The tree and table representation
of CTree derived staging groups (

Figure 2), and MOB derived staging groups (Figure 3) are also provided. For all three staging
systems, patients with metastatic tumors (M1) are grouped in to a separate stage. Both MOB
derived and CART derived staging systems eventually have five staging groups. Stage IV for
MOB and CART staging systems is the same (T4). Ctree and CART staging systems have the
same stage I (T1).
A

B
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N0
N1
N2A
N2B
N2C
N3

T1
I
I
I
I
I
I

T2
II
II
II
II
II
III

T3
III
III
III
III
III
III

T4A
IV
IV
IV
IV
IV
IV

T4B
IV
IV
IV
IV
IV
IV

Figure 1 Staging groups derived using CART algorithm (A) Staging groups and 3-year OS (B)
Clinical T and N categories for each staging group
A

B
N0
N1

T1
I
I

T2
II
II

T3
II
II

T4A
III
III

T4B
III
III

N2A

I

II

II

III

III

N2B
N2C
N3

I
I
I

II
II
II

II
III
III

III
III
III

III
III
III

Figure 2 Staging groups derived using CTree algorithm (A) Staging groups and 3-year OS (B)
Clinical T and N categories for each staging group
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A

B
N0
N1
N2A
N2B
N2C
N3

T1
I
I
I
II
II
II

T2
I
I
I
II
II
II

T3
III
III
III
III
III
III

T4A
IV
IV
IV
IV
IV
IV

T4B
IV
IV
IV
IV
IV
IV

Figure 3 Staging groups derived using MOB algorithm (A) Staging groups and 3-year OS (B)
Clinical T and N categories for each staging group

Survival Analysis using AJCC and Recursive Partitioning Derived
Staging groups
Kaplan-Meier survival curves with number-at-risk table for the AJCC, CART, CTree and MOB
staging groups appear in

Figure 4. Adjusted hazard ratios and 3-year overall survival with their 95% CI are provided in
Table 3.

15

In all four cases, overall log-rank test demonstrated statistically significant difference in survival
rate across staging groups (P < 0.01). In three staging systems based on recursive partitioning, a
monotonic reduction in 3-year OS according to higher TNM stages can be seen. In AJCC staging
system, however, pairwise log-rank tests showed that no significant difference exist between
Stage I and Stage II (P = 0.48), Stage II and Stage III (P = 0.53) and Stage III and Stage IVA (P
= 0.011). Table 2 also suggests relatively indistinguishable 3-year OS for AJCC staging group I
to group IVA (92%, 87%, 89%, 85% respectively).
A

B

16

C

D

Figure 4 Overall Kaplan-Meier survival curve by (A) AJCC stages (B) CART stages (C) CTree
stages (D) MOB stages
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Table 3 Three-year OS, AHR with 95% CIs for AJCC, CART, CTree and MOB staging systems
Stage

No. of
patients

3-year Overall Survival
(95% Confidence Interval)

AJCC
I
182
92.11% (88.03%, 96.38%)
II
394
87.12% (82.98%, 91.46%)
III
1173
89.01% (86.78%, 91.29%)
IVA
3565
85.38% (83.90%, 86.88%)
IVB
312
71.02% (64.80%, 77.83%)
IVC
86
34.84% (24.29%, 49.96%)
CART
I
1726
92.02% (90.43%, 93.65%)
II
2375
86.73% (84.95%, 88.55%)
III
955
80.59% (77.54%, 83.77%)
IV
570
70.34% (65.75%, 75.25%)
V
86
34.84% (24.29%, 49.96%)
CTree
I
1726
92.02% (90.43%, 93.65%)
II
3090
85.83% (84.25%, 87.44%)
III
810
71.49% (67.68%, 75.50%)
IV
86
34.84% (24.29%, 49.96%)
MOB
I
2001
90.65% (89.06%, 92.28%)
II
2183
86.91% (85.06%, 88.81%)
III
872
81.23% (78.10%, 84.49%)
IV
570
70.34% (65.75%, 75.25%)
V
86
34.84% (24.29%, 49.96%)
0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

Hazard
Ratio

p-value for
HR

Ref
1.290 (0.696, 2.392)
1.416, (0.805, 2.491)
1.990 (1.156, 3.425)
4.794 (2.675, 8.591)
10.632 ((5.841, 19.353)

0.418
0.228
0.013 *
< .001 ***
< .001 ***

Ref
1.383 (1.101, 1.737)
2.477 (1.933, 3.175)
3.726 (2.882, 4.819)
9.710 (6.884, 13.695)

0.00534 **
< .001 ***
< .001 ***
< .001 ***

Ref
1.553 (1.251, 1.929)
3.613 (2.838, 4.60)
9.682 (6.866, 13.655)

< .001 ***
< .001 ***
< .001 ***

Ref
1.622 (1.305, 2.015)
2.456 (1.932, 3.122)
3.823 (2.999, 4.872)
9.801 (7.0413, 13.642)

< .001 ***
< .001 ***
< .001 ***
< .001 ***

Performance Evaluation of the AJCC and Recursive Partitioning
Derived Staging systems
Comparing the seventh edition AJCC staging system and the three recursive partitioning derived
staging systems using Groome’s four criteria, the MOB stage performed best overall, followed
by CART and CTree stage. The AJCC stage performed least well. The comparative result was
also validated by bootstrap. (Table 4)
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CART stage achieved best hazard consistency score, indicating that patients within each CART
staging group have relatively consistent survival experience. With the worst hazard consistency
score, AJCC stage has heterogeneous patients in each group with regard to survival. Hazard
discrimination measures the evenness of the distribution of survival curves across groups and the
span of the curves. With the patients of M1 disease excluded, CTree stage distributed most
evenly across group (absolute differences in survival rates are at least 2%, 5%, 6%, and 4% for
AJCC, CART, CTree and MOB respectively). All four staging systems have similar span of the
curves (differences in survival rates between the first and the last stage are 21%, 22%, 21% and
20% respectively) according to Table 2. With the greatest number of subgroups, the AJCC
staging scheme outperformed other systems with regard to hazard discrimination. The MOB
stage derived by parametric model-based recursive partitioning has a Brier score of 13.54%,
indicating a greater predictive power than other systems, whereas the AJCC stage has worst
discriminative ability. The three recursive partitioning derived staging systems are well-balanced
with respect to the number of patients in each staging group, while the sample size distribution is
unbalanced for AJCC stages.
Table 4 Performance evaluation of AJCC, CART, CTree and MOB staging systems
Evaluation Criteria

AJCC Stage

Performance evaluation for the study cohort
% Hazard consistency
Score
Rank
Hazard discrimination
Score
Rank
Outcome prediction (% variance explained)
Score
Rank
Balance
Score
Rank
Overall score

2.51
1.00
4
0.13
0.00
1
11.51
1.00
4
0.88
1.00
4
0.71
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CART Stage CTree Stage MOB Stage
1.27
0.00
1
0.43
0.95
3
12.29
0.61
3
0.46
0.06
2
0.45

1.49
0.18
2
0.44
1.00
4
12.31
0.61
2
0.43
0.00
1
0.51

1.56
0.23
3
0.35
0.71
2
13.54
0.00
1
0.49
0.12
3
0.29

Overall rank
Performance evaluation using bootstrap (n=1000)
% Hazard consistency
Score
Rank
Hazard discrimination
Score
Rank
Outcome prediction (% variance explained)
Score
Rank
Balance
Score
Rank
Overall score
Overall rank
% Rank=1
% Rank=2

20

4

2

3

1

2.51
0.95
3.89
0.17
0.02
1.11
11.85
0.75
3.17
0.88
1.00
4.00
0.60
4
0.04
0.07

1.71
0.18
2.22
0.25
0.42
2.48
12.53
0.53
2.66
0.46
0.06
1.93
0.45
2
0.20
0.29

1.70
0.16
1.93
0.35
1.00
3.98
12.51
0.52
2.69
0.43
0.00
1.07
0.47
3
0.31
0.25

1.71
0.17
2.08
0.25
0.42
2.43
13.85
0.08
1.47
0.49
0.12
3.00
0.34
1
0.45
0.39

DISCUSSION
The seventh edition AJCC staging system was derived empirically from HPV-unrelated OPC and
has been shown to be inadequate to predict survival for HPV-related OPC. Hence, this article
used three recursive partitioning algorithms, CART, CTree and MOB to derive a new staging
scheme based on NCDB patients. In addition to proposing a new staging system valid for HPVrelated OPC, the other goal of this study was to compare the recursive partitioning algorithms
with respect to the performance of the staging systems derived by them, and suggest the best
algorithm for cancer staging.
The importance of cancer staging lies in its application in planning treatment, assessing
prognosis, stratifying patients for therapeutic studies, evaluating treatment outcome, and
supporting cancer control. Therefore, unlike model validation which merely uses measures of
predictive power or goodness of fit as assessing criteria, the evaluation for staging schemes need
to take their applicability in real life into account. Groome et al. (2001) identified four
characteristic for useful staging systems: similar survival outcomes within each group;
heterogeneous survival between groups; high predictive ability; and balanced distribution across
groups. These four criteria were then used for evaluation of the standard AJCC and three derived
RPA staging schemes.
According to evaluation analysis based on the study cohort and bootstrap validation (Table 4),
MOB derived staging system has best predictive ability and overall performance. Thus it became
the stage scheme for HPV-related OPC recommended by this article. Patients were grouped into
four stages: Stage I (T1-2N0-2a), Stage II (T1-2N2b-3), Stage III (T3), and Stage IV (T4). Stage
V is reserved for metastatic patients (M1).
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MOB is a parametric model-based recursive partitioning algorithm developed to address the
issue of constant fits in nodes. Rather than fitting a single global model using one set of
covariates, MOB examines the possibility to partition the observations using another set of
variables and construct locally well-fitted models in each node. Since a convention of OPC
staging is to group patients by the combination of clinical T, N and M categories, other
covariates affecting survival e.g. age, gender and treatment cannot be entered into the model if
we use non-parametric recursive partitioning algorithms such as CART and CTree. The benefit
of MOB is then very clear; it adjusts for covariates affecting survival by fitting multivariate cox
models with those covariates locally and splitting a node over T, N or M if significant parameter
instability is observed.
Based on empirical analysis in this article and theoretical advantage of MOB algorithm, MOB is
recommended as a default method for future TNM cancer staging.
There are limitations of this study that worth discussion. The median follow-up is 28.5 months
for the study cohort. This only allows an extrapolation to three-year overall survival in analysis,
making it impossible to observe late distant metastases occurring 3 years or more after treatment
that has been described for HPV-related disease (Huang et al., 2013). In addition, NCDB does
not provide information on smoking history, a strong predictor of increased risk of failure
(Gillison et al., 2011). Even though internal validation was performed with bootstrap, studies
using independent datasets for external validation are needed to confirm the recommended
recursive partitioning algorithm as well as the staging scheme.
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